Antibody-screening methods to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) need to be validated. We evaluated SARS-CoV-2 IgG and IgA ELISAs in conjunction with the EUROLabworkstation (Euroimmun, Lübeck, Germany). Overall specificities were 91.9% and 73.0% for IgG and IgA ELISAs, respectively. Of 39 coronavirus disease patients, 13 were IgG and IgA positive and 11 IgA alone at sampling. IgGs and IgAs were respectively detected at a median of 12 and 11 days after symptom onset.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, IgG, serology, IgA, commercial, 【초록키워드】 coronavirus disease, coronavirus, ELISA, specificity, Germany, patients, ELISAs, SARS-CoV-2 IgG, symptom onset, acute respiratory syndrome, positive, Lubeck, detect, evaluated, median, 【제목키워드】 coronavirus disease, ELISA, Patient, automated, SARS-CoV-2 IgG,
【저자키워드】 COVID-19, SARS-CoV-2, IgG, serology, IgA, commercial, 【초록키워드】 coronavirus disease, coronavirus, ELISA, specificity, Germany, patients, ELISAs, SARS-CoV-2 IgG, symptom onset, acute respiratory syndrome, positive, Lubeck, detect, evaluated, median, 【제목키워드】 coronavirus disease, ELISA, Patient, automated, SARS-CoV-2 IgG,